Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Advances Pipeline With Yondelis, Carisbamate Filings

This article was originally published in The Pink Sheet Daily

Executive Summary

Company is on track to achieve goal of filing seven to 10 new products from the beginning of 2008 through end of 2010, CEO Weldon says.
Advertisement

Related Content

A Double Dose of Doxil: FDA Advisory Committee Will Review Two Applications
A Double Dose of Doxil: FDA Advisory Committee Will Review Two Applications
CTI Plans To Spin Off Systems Medicine As Pharmacogenomics Company Apana
CTI Plans To Spin Off Systems Medicine As Pharmacogenomics Company Apana
FDA To Centocor: Show Me The REMS
J&J/Alza’s Ionsys To Launch In 2007
J&J/Alza’s Ionsys To Launch In 2007

Topics

Advertisement
UsernamePublicRestriction

Register

PS068486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel